The impact of pharmaceutical care interventions for medication underuse in older people: A systematic review and meta-analysis

British Journal of Clinical Pharmacology

Volumn 80, Issue 4, 2015, Pages 768-776

  Meid, Andreas D ^a   Lampert, Anette ^a   Burnett, Alina ^a,b   Seidling, Hanna M ^a   Haefeli, Walter E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

elderly; inappropriate prescribing; medication reviews; medication underuse; meta analysis; systematic literature review

Indexed keywords

ARTICLE; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PHARMACEUTICAL CARE; PRIORITY JOURNAL; SCREENING; STUDY DESIGN; SYSTEMATIC REVIEW; AGED; DRUG UTILIZATION REVIEW; MEDICATION ERROR; PHARMACY; PREVENTION AND CONTROL; STATISTICS AND NUMERICAL DATA;

AGED; DRUG UTILIZATION REVIEW; HUMANS; MEDICATION ERRORS; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACEUTICAL SERVICES;

EID: 84942511868     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12657     Document Type: Article

References (44)

1. Christensen K, Doblhammer G, Rau R, Vaupel JW,. Ageing populations: the challenges ahead. Lancet 2009; 374: 1196-208.
2. Shi S, Morike K, Klotz U,. The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol 2008; 64: 183-99.
3. Laroche ML, Charmes JP, Bouthier F, Merle L,. Inappropriate medications in the elderly. Clin Pharmacol Ther 2009; 85: 94-7.
4. Hanlon JT, Schmader KE, Ruby CM, Weinberger M,. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001; 49: 200-9.
5. Cherubini A, Corsonello A, Lattanzio F,. Underprescription of beneficial medicines in older people: causes, consequences and prevention. Drugs Aging 2012; 29: 463-75.
6. Simonson W, Feinberg JL,. Medication-related problems in the elderly: defining the issues and identifying solutions. Drugs Aging 2005; 22: 559-69.
7. Hill-Taylor B, Sketris I, Hayden J, Byrne S, O'Sullivan D, Christie R,. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther 2013; 38: 360-72.
8. Lipton HL, Bero LA, Bird JA, McPhee SJ,. Undermedication among geriatric outpatients: results of a randomized controlled trial. Ann Rev Gerontol Ger 1992; 12: 95-108.
9. Beer C, Hyde Z, Almeida OP, Norman P, Hankey GJ, Yeap BB, Flicker L,. Quality use of medicines and health outcomes among a cohort of community dwelling older men: an observational study. Br J Clin Pharmacol 2011; 71: 592-9.
10. Castelino RL, Bajorek BV, Chen TF,. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services. Ann Pharmacother 2009; 43: 1096-106.
11. Topinkova E, Baeyens JP, Michel JP, Lang PO,. Evidence-based strategies for the optimization of pharmacotherapy in older people. Drugs Aging 2012; 29: 477-94.
12. Lowe CJ, Petty DR, Zermansky AG, Raynor DK,. Development of a method for clinical medication review by a pharmacist in general practice. Pharm World Sci 2000; 22: 121-6.
13. Greenwald JL, Halasyamani L, Greene J, LaCivita C, Stucky E, Benjamin B, Reid W, Griffin FA, Vaida AJ, Williams MV,. Making inpatient medication reconciliation patient centered, clinically relevant and implementable: a consensus statement on key principles and necessary first steps. J Hosp Med 2010; 5: 477-85.
14. O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher P,. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 2014; 44: 213-8.
15. Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D,. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72-83.
16. Wenger NS, Roth CP, Shekelle P, ACOVE Investigators. Introduction to the assessing care of vulnerable elders-3 quality indicator measurement set. J Am Geriatr Soc 2007; 55 (Suppl. 2): S247-52.
17. Wenger NS, Shekelle PG,. Assessing care of vulnerable elders: ACOVE project overview. Ann Intern Med 2001; 135: 642-6.
18. Shekelle PG, MacLean CH, Morton SC, Wenger NS,. Acove quality indicators. Ann Intern Med 2001; 135: 653-67.
19. Higgins JPT, Green S,. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration 2011.
20. Freigofas J, Haefeli WE, Schottker B, Brenner H, Quinzler R,. Indirect evidence for proton pump inhibitor failure in patients taking them independent of meals. Pharmacoepidemiol Drug Saf 2014; 23: 768-72.
21. Wei Y, Higgins JP,. Estimating within-study covariances in multivariate meta-analysis with multiple outcomes. Stat Med 2013; 32: 1191-205.
22. Berkey CS, Hoaglin DC, Antczak-Bouckoms A, Mosteller F, Colditz GA,. Meta-analysis of multiple outcomes by regression with random effects. Stat Med 1998; 17: 2537-50.
23. Viechtbauer W,. Conducting meta-analyses in R with the metafor package. J Stat Softw 2010; 36: 1-48.
24. Riley RD, Thompson JR, Abrams KR,. An alternative model for bivariate random-effects meta-analysis when the within-study correlations are unknown. Biostatistics 2008; 9: 172-86.
25. Bujkiewicz S, Thompson JR, Sutton AJ, Cooper NJ, Harrison MJ, Symmons DP, Abrams KR,. Multivariate meta-analysis of mixed outcomes: a Bayesian approach. Stat Med 2013; 32: 3926-43.
26. Gallagher PF, O'Connor MN, O'Mahony D,. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 2011; 89: 845-54.
27. Frankenthal D, Lerman Y, Kalendaryev E, Lerman Y,. Intervention with the screening tool of older persons potentially inappropriate prescriptions/screening tool to alert doctors to right treatment criteria in elderly residents of a chronic geriatric facility: a randomized clinical trial. J Am Geriatr Soc 2014; 62: 1658-65.
28. Garcia-Gollarte F, Baleriola-Julvez J, Ferrero-Lopez I, Cuenllas-Diaz A, Cruz-Jentoft AJ,. An educational intervention on drug use in nursing homes improves health outcomes resource utilization and reduces inappropriate drug prescription. J Am Med Dir Assoc 2014; 15: 885-91.
29. Gillespie U, Alassaad A, Hammarlund-Udenaes M, Morlin C, Henrohn D, Bertilsson M, Melhus H,. Effects of pharmacists' interventions on appropriateness of prescribing and evaluation of the instruments' (MAI, STOPP and STARTs') ability to predict hospitalization-analyses from a randomized controlled trial. PLoS One 2013; 8: e62401.
30. Alassaad A, Bertilsson M, Gillespie U, Sundstrom J, Hammarlund-Udenaes M, Melhus H,. The effects of pharmacist intervention on emergency department visits in patients 80 years and older: subgroup analyses by number of prescribed drugs and appropriate prescribing. PLoS One 2014; 9: e111797.
31. Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, Downie G, Seymour DG,. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001; 30: 205-11.
32. Schmader KE, Hanlon JT, Pieper CF, Sloane R, Ruby CM, Twersky J, Francis SD, Branch LG, Lindblad CI, Artz M, Weinberger M, Feussner JR, Cohen HJ,. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004; 116: 394-401.
33. Spinewine A, Swine C, Dhillon S, Lambert P, Nachega JB, Wilmotte L, Tulkens PM,. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc 2007; 55: 658-65.
34. Verrue C, Mehuys E, Boussery K, Adriaens E, Remon JP, Petrovic M,. A pharmacist-conducted medication review in nursing home residents: impact on the appropriateness of prescribing. Acta Clin Belg 2012; 67: 423-9.
35. Forsetlund L, Eike MC, Gjerberg E, Vist GE,. Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomised controlled trials. BMC Geriatr 2011; 11: 16.
36. Gallagher P, Lang PO, Cherubini A, Topinkova E, Cruz-Jentoft A, Montero Errasquin B, Madlova P, Gasperini B, Baeyens H, Baeyens JP, Michel JP, O'Mahony D,. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol 2011; 67: 1175-88.
37. Ryan C, O'Mahony D, Kennedy J, Weedle P, Byrne S,. Potentially inappropriate prescribing in an Irish elderly population in primary care. Br J Clin Pharmacol 2009; 68: 936-47.
38. Blaschke TF, Osterberg L, Vrijens B, Urquhart J,. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol 2012; 52: 275-301.
39. MacLaughlin EJ, Raehl CL, Treadway AK, Sterling TL, Zoller DP, Bond CA,. Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging 2005; 22: 231-55.
40. Kaiser RM, Schmader KE, Pieper CF, Lindblad CI, Ruby CM, Hanlon JT,. Therapeutic failure-related hospitalisations in the frail elderly. Drugs Aging 2006; 23: 579-86.
41. Holmes HM, Hayley DC, Alexander GC, Sachs GA,. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006; 166: 605-9.
42. Barber N,. What constitutes good prescribing? BMJ 1995; 310: 923-5.
43. Lenaerts E, De Knijf F, Schoenmakers B,. Appropriate prescribing for older people: a new tool for the general practitioner. J Frailty & Aging 2013; 2: 8-14.
44. Brown P, Brunnhuber K, Chalkidou K, Chalmers I, Clarke M, Fenton M, Forbes C, Glanville J, Hicks NJ, Moody J, Twaddle S, Timimi H, Young P,. How to formulate research recommendations. BMJ 2006; 333: 804-6.